Detalles de la búsqueda
1.
Effect of montelukast for treatment of asthma in cigarette smokers.
J Allergy Clin Immunol
; 131(3): 763-71, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23380218
2.
Indirect comparison of pembrolizumab monotherapy versus nivolumab + ipilimumab in first-line metastatic lung cancer.
Immunotherapy
; 14(5): 295-307, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35073727
3.
The efficacy and tolerability of inhaled montelukast plus inhaled mometasone compared with mometasone alone in patients with chronic asthma.
J Asthma
; 48(5): 495-502, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21545249
4.
Cost-effectiveness of pembrolizumab + chemotherapy versus chemotherapy and pembrolizumab monotherapy in first line treatment of NSCLC in the US - updated analyses with additional trial follow-up.
J Med Econ
; 24(1): 792-805, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34098842
5.
Pembrolizumab+chemotherapy versus atezolizumab+chemotherapy+/-bevacizumab for the first-line treatment of non-squamous NSCLC: A matching-adjusted indirect comparison.
Lung Cancer
; 155: 175-182, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33839603
6.
A phase I randomized, placebo-controlled, dose-exploration study of single-dose inhaled montelukast in patients with chronic asthma.
J Asthma
; 47(10): 1078-84, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20936994
7.
A Matching-Adjusted Indirect Comparison of Pembrolizumab + Chemotherapy vs. Nivolumab + Ipilimumab as First-Line Therapies in Patients with PD-L1 TPS ≥1% Metastatic NSCLC.
Cancers (Basel)
; 12(12)2020 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33291810
8.
Cost-effectiveness of pembrolizumab in combination with chemotherapy versus chemotherapy and pembrolizumab monotherapy in the first-line treatment of squamous non-small-cell lung cancer in the US.
Curr Med Res Opin
; 35(7): 1241-1256, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30649973
9.
Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater.
J Clin Oncol
; 37(7): 537-546, 2019 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30620668
10.
Efficacy of the selective extrasynaptic GABA A agonist, gaboxadol, in a model of transient insomnia: a randomized, controlled clinical trial.
Sleep Med
; 9(4): 393-402, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17765013
11.
Cost-effectiveness of pembrolizumab in combination with chemotherapy in the 1st line treatment of non-squamous NSCLC in the US.
J Med Econ
; 21(12): 1191-1205, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30188231
12.
Alendronate prevents loss of bone density associated with discontinuation of hormone replacement therapy: a randomized controlled trial.
Arch Intern Med
; 163(7): 789-94, 2003 Apr 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-12695269
13.
A comparison of visual analog scale and categorical ratings of headache pain in a randomized controlled clinical trial with migraine patients.
Pain
; 93(2): 185-190, 2001 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-11427330
14.
Weekly oral alendronic Acid in male osteoporosis.
Clin Drug Investig
; 24(6): 333-41, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-17516720
15.
Etoricoxib in the treatment of Korean patients with osteoarthritis in a double-blind, randomized controlled trial.
Curr Med Res Opin
; 30(12): 2399-408, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25133963
16.
Effect of gaboxadol on patient-reported measures of sleep and waking function in patients with Primary Insomnia: results from two randomized, controlled, 3-month studies.
J Clin Sleep Med
; 6(1): 30-9, 2010 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20191935
Resultados
1 -
16
de 16
1
Próxima >
>>